Part 1
Part 2
Part 3
Part 5
Description
Conventional pain treatments included opiate and over-the-counter medications, whereas the most frequently endorsed lifetime complementary and alternative medicine pain treatmentsincluded stretching, physical exercise, physical therapy, heat therapy, and prayer. The global market for Conventional and Alternative Pain Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Conventional and Alternative Pain Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Conventional and Alternative Pain Treatment by region & country, by Type, and by Application.
The Conventional and Alternative Pain Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conventional and Alternative Pain Treatment.
Market Segmentation
Report Metric
Details
Report Title
Conventional and Alternative Pain Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Conventional and Alternative Pain Treatment Companies Covered
Abbott Laboratories, Aphria Inc., Assertio Therapeutics, Baxter International, Boston Scientific Corp., Collegium Pharmaceuticals Inc., Cronos Group Inc., Eli Lilly, Grunenthal Gmbh, Horizon Therapeutics Plc, Johnson and Johnson, Pfizer Inc.
Global Conventional and Alternative Pain Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Conventional and Alternative Pain Treatment Market, Segment by Type
Electrotherapy
Spinal Cord Stimulator
Other Devices
Global Conventional and Alternative Pain Treatment Market, Segment by Application
Home Care
Hospice
Hospitals
Pain Clinics
Skilled Nursing Facilities
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Conventional and Alternative Pain Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Conventional and Alternative Pain Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Conventional and Alternative Pain Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Conventional and Alternative Pain Treatment Product Introduction
1.2 Global Conventional and Alternative Pain Treatment Market Size Forecast
1.3 Conventional and Alternative Pain Treatment Market Trends & Drivers
1.3.1 Conventional and Alternative Pain Treatment Industry Trends
1.3.2 Conventional and Alternative Pain Treatment Market Drivers & Opportunity
1.3.3 Conventional and Alternative Pain Treatment Market Challenges
1.3.4 Conventional and Alternative Pain Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Conventional and Alternative Pain Treatment Players Revenue Ranking (2023)
2.2 Global Conventional and Alternative Pain Treatment Revenue by Company (2019-2024)
2.3 Key Companies Conventional and Alternative Pain Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Conventional and Alternative Pain Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Conventional and Alternative Pain Treatment
2.6 Conventional and Alternative Pain Treatment Market Competitive Analysis
2.6.1 Conventional and Alternative Pain Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Conventional and Alternative Pain Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conventional and Alternative Pain Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Electrotherapy
3.1.2 Spinal Cord Stimulator
3.1.3 Other Devices
3.2 Global Conventional and Alternative Pain Treatment Sales Value by Type
3.2.1 Global Conventional and Alternative Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Conventional and Alternative Pain Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Conventional and Alternative Pain Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Home Care
4.1.2 Hospice
4.1.3 Hospitals
4.1.4 Pain Clinics
4.1.5 Skilled Nursing Facilities
4.2 Global Conventional and Alternative Pain Treatment Sales Value by Application
4.2.1 Global Conventional and Alternative Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Conventional and Alternative Pain Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Conventional and Alternative Pain Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Conventional and Alternative Pain Treatment Sales Value by Region
5.1.1 Global Conventional and Alternative Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Conventional and Alternative Pain Treatment Sales Value by Region (2019-2024)
5.1.3 Global Conventional and Alternative Pain Treatment Sales Value by Region (2025-2030)
5.1.4 Global Conventional and Alternative Pain Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Conventional and Alternative Pain Treatment Sales Value, 2019-2030
5.2.2 North America Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Conventional and Alternative Pain Treatment Sales Value, 2019-2030
5.3.2 Europe Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Conventional and Alternative Pain Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Conventional and Alternative Pain Treatment Sales Value, 2019-2030
5.5.2 South America Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Conventional and Alternative Pain Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Conventional and Alternative Pain Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Conventional and Alternative Pain Treatment Sales Value
6.3 United States
6.3.1 United States Conventional and Alternative Pain Treatment Sales Value, 2019-2030
6.3.2 United States Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Conventional and Alternative Pain Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Conventional and Alternative Pain Treatment Sales Value, 2019-2030
6.4.2 Europe Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Conventional and Alternative Pain Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Conventional and Alternative Pain Treatment Sales Value, 2019-2030
6.5.2 China Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Conventional and Alternative Pain Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Conventional and Alternative Pain Treatment Sales Value, 2019-2030
6.6.2 Japan Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Conventional and Alternative Pain Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Conventional and Alternative Pain Treatment Sales Value, 2019-2030
6.7.2 South Korea Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Conventional and Alternative Pain Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Conventional and Alternative Pain Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Conventional and Alternative Pain Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Conventional and Alternative Pain Treatment Sales Value, 2019-2030
6.9.2 India Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Conventional and Alternative Pain Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Conventional and Alternative Pain Treatment Products, Services and Solutions
7.1.4 Abbott Laboratories Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Aphria Inc.
7.2.1 Aphria Inc. Profile
7.2.2 Aphria Inc. Main Business
7.2.3 Aphria Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
7.2.4 Aphria Inc. Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Aphria Inc. Recent Developments
7.3 Assertio Therapeutics
7.3.1 Assertio Therapeutics Profile
7.3.2 Assertio Therapeutics Main Business
7.3.3 Assertio Therapeutics Conventional and Alternative Pain Treatment Products, Services and Solutions
7.3.4 Assertio Therapeutics Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Baxter International Recent Developments
7.4 Baxter International
7.4.1 Baxter International Profile
7.4.2 Baxter International Main Business
7.4.3 Baxter International Conventional and Alternative Pain Treatment Products, Services and Solutions
7.4.4 Baxter International Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Baxter International Recent Developments
7.5 Boston Scientific Corp.
7.5.1 Boston Scientific Corp. Profile
7.5.2 Boston Scientific Corp. Main Business
7.5.3 Boston Scientific Corp. Conventional and Alternative Pain Treatment Products, Services and Solutions
7.5.4 Boston Scientific Corp. Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Boston Scientific Corp. Recent Developments
7.6 Collegium Pharmaceuticals Inc.
7.6.1 Collegium Pharmaceuticals Inc. Profile
7.6.2 Collegium Pharmaceuticals Inc. Main Business
7.6.3 Collegium Pharmaceuticals Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
7.6.4 Collegium Pharmaceuticals Inc. Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Collegium Pharmaceuticals Inc. Recent Developments
7.7 Cronos Group Inc.
7.7.1 Cronos Group Inc. Profile
7.7.2 Cronos Group Inc. Main Business
7.7.3 Cronos Group Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
7.7.4 Cronos Group Inc. Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Cronos Group Inc. Recent Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Profile
7.8.2 Eli Lilly Main Business
7.8.3 Eli Lilly Conventional and Alternative Pain Treatment Products, Services and Solutions
7.8.4 Eli Lilly Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Eli Lilly Recent Developments
7.9 Grunenthal Gmbh
7.9.1 Grunenthal Gmbh Profile
7.9.2 Grunenthal Gmbh Main Business
7.9.3 Grunenthal Gmbh Conventional and Alternative Pain Treatment Products, Services and Solutions
7.9.4 Grunenthal Gmbh Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Grunenthal Gmbh Recent Developments
7.10 Horizon Therapeutics Plc
7.10.1 Horizon Therapeutics Plc Profile
7.10.2 Horizon Therapeutics Plc Main Business
7.10.3 Horizon Therapeutics Plc Conventional and Alternative Pain Treatment Products, Services and Solutions
7.10.4 Horizon Therapeutics Plc Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Horizon Therapeutics Plc Recent Developments
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Profile
7.11.2 Johnson and Johnson Main Business
7.11.3 Johnson and Johnson Conventional and Alternative Pain Treatment Products, Services and Solutions
7.11.4 Johnson and Johnson Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Johnson and Johnson Recent Developments
7.12 Pfizer Inc.
7.12.1 Pfizer Inc. Profile
7.12.2 Pfizer Inc. Main Business
7.12.3 Pfizer Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
7.12.4 Pfizer Inc. Conventional and Alternative Pain Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Pfizer Inc. Recent Developments
8 Industry Chain Analysis
8.1 Conventional and Alternative Pain Treatment Industrial Chain
8.2 Conventional and Alternative Pain Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Conventional and Alternative Pain Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Conventional and Alternative Pain Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Conventional and Alternative Pain Treatment Market Trends
Table 2. Conventional and Alternative Pain Treatment Market Drivers & Opportunity
Table 3. Conventional and Alternative Pain Treatment Market Challenges
Table 4. Conventional and Alternative Pain Treatment Market Restraints
Table 5. Global Conventional and Alternative Pain Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Conventional and Alternative Pain Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Conventional and Alternative Pain Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Conventional and Alternative Pain Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Conventional and Alternative Pain Treatment
Table 10. Global Conventional and Alternative Pain Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conventional and Alternative Pain Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Conventional and Alternative Pain Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Conventional and Alternative Pain Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Conventional and Alternative Pain Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Conventional and Alternative Pain Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Conventional and Alternative Pain Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Conventional and Alternative Pain Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Conventional and Alternative Pain Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Conventional and Alternative Pain Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Conventional and Alternative Pain Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Conventional and Alternative Pain Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Conventional and Alternative Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Conventional and Alternative Pain Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Conventional and Alternative Pain Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Conventional and Alternative Pain Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Conventional and Alternative Pain Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Conventional and Alternative Pain Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Conventional and Alternative Pain Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Conventional and Alternative Pain Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. Aphria Inc. Basic Information List
Table 37. Aphria Inc. Description and Business Overview
Table 38. Aphria Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Aphria Inc. (2019-2024)
Table 40. Aphria Inc. Recent Developments
Table 41. Assertio Therapeutics Basic Information List
Table 42. Assertio Therapeutics Description and Business Overview
Table 43. Assertio Therapeutics Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Assertio Therapeutics (2019-2024)
Table 45. Assertio Therapeutics Recent Developments
Table 46. Baxter International Basic Information List
Table 47. Baxter International Description and Business Overview
Table 48. Baxter International Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Baxter International (2019-2024)
Table 50. Baxter International Recent Developments
Table 51. Boston Scientific Corp. Basic Information List
Table 52. Boston Scientific Corp. Description and Business Overview
Table 53. Boston Scientific Corp. Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Boston Scientific Corp. (2019-2024)
Table 55. Boston Scientific Corp. Recent Developments
Table 56. Collegium Pharmaceuticals Inc. Basic Information List
Table 57. Collegium Pharmaceuticals Inc. Description and Business Overview
Table 58. Collegium Pharmaceuticals Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Collegium Pharmaceuticals Inc. (2019-2024)
Table 60. Collegium Pharmaceuticals Inc. Recent Developments
Table 61. Cronos Group Inc. Basic Information List
Table 62. Cronos Group Inc. Description and Business Overview
Table 63. Cronos Group Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Cronos Group Inc. (2019-2024)
Table 65. Cronos Group Inc. Recent Developments
Table 66. Eli Lilly Basic Information List
Table 67. Eli Lilly Description and Business Overview
Table 68. Eli Lilly Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Eli Lilly (2019-2024)
Table 70. Eli Lilly Recent Developments
Table 71. Grunenthal Gmbh Basic Information List
Table 72. Grunenthal Gmbh Description and Business Overview
Table 73. Grunenthal Gmbh Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Grunenthal Gmbh (2019-2024)
Table 75. Grunenthal Gmbh Recent Developments
Table 76. Horizon Therapeutics Plc Basic Information List
Table 77. Horizon Therapeutics Plc Description and Business Overview
Table 78. Horizon Therapeutics Plc Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Horizon Therapeutics Plc (2019-2024)
Table 80. Horizon Therapeutics Plc Recent Developments
Table 81. Johnson and Johnson Basic Information List
Table 82. Johnson and Johnson Description and Business Overview
Table 83. Johnson and Johnson Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Johnson and Johnson (2019-2024)
Table 85. Johnson and Johnson Recent Developments
Table 86. Pfizer Inc. Basic Information List
Table 87. Pfizer Inc. Description and Business Overview
Table 88. Pfizer Inc. Conventional and Alternative Pain Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Conventional and Alternative Pain Treatment Business of Pfizer Inc. (2019-2024)
Table 90. Pfizer Inc. Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Conventional and Alternative Pain Treatment Downstream Customers
Table 94. Conventional and Alternative Pain Treatment Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Conventional and Alternative Pain Treatment Product Picture
Figure 2. Global Conventional and Alternative Pain Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Conventional and Alternative Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Conventional and Alternative Pain Treatment Report Years Considered
Figure 5. Global Conventional and Alternative Pain Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Conventional and Alternative Pain Treatment Revenue in 2023
Figure 7. Conventional and Alternative Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Electrotherapy Picture
Figure 9. Spinal Cord Stimulator Picture
Figure 10. Other Devices Picture
Figure 11. Global Conventional and Alternative Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Conventional and Alternative Pain Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Home Care
Figure 14. Product Picture of Hospice
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Pain Clinics
Figure 17. Product Picture of Skilled Nursing Facilities
Figure 18. Global Conventional and Alternative Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Conventional and Alternative Pain Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Conventional and Alternative Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Conventional and Alternative Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Conventional and Alternative Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Conventional and Alternative Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Conventional and Alternative Pain Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Conventional and Alternative Pain Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Conventional and Alternative Pain Treatment Sales Value (%), (2019-2030)
Figure 31. United States Conventional and Alternative Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Conventional and Alternative Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Conventional and Alternative Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Conventional and Alternative Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. China Conventional and Alternative Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. China Conventional and Alternative Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Conventional and Alternative Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Conventional and Alternative Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Conventional and Alternative Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Conventional and Alternative Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Conventional and Alternative Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Conventional and Alternative Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. India Conventional and Alternative Pain Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Conventional and Alternative Pain Treatment Sales Value by Type (%), 2023 VS 2030
Figure 51. India Conventional and Alternative Pain Treatment Sales Value by Application (%), 2023 VS 2030
Figure 52. Conventional and Alternative Pain Treatment Industrial Chain
Figure 53. Conventional and Alternative Pain Treatment Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Description
Conventional pain treatments included opiate and over-the-counter medications, whereas the most frequently endorsed lifetime complementary and alternative medicine pain treatmentsincluded stretching, physical exercise, physical therapy, heat therapy, and prayer. The global market for Conventional and Alternative Pain Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Conventional and Alternative Pain Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Conventional and Alternative Pain Treatment by region & country, by Type, and by Application.
The Conventional and Alternative Pain Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conventional and Alternative Pain Treatment.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Conventional and Alternative Pain Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Conventional and Alternative Pain Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Conventional and Alternative Pain Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now